Editorial
doi: 10.1093/jnci/84.4.218.
Active cancer therapy combining 13-cis-retinoic acid with interferon-alpha
- PMID: 1734081
- DOI: 10.1093/jnci/84.4.218
Item in Clipboard
Editorial
Active cancer therapy combining 13-cis-retinoic acid with interferon-alpha
J Natl Cancer Inst.
.
No abstract available
Comment on
-
13-cis-retinoic acid and interferon alpha-2a: effective combination therapy for advanced squamous cell carcinoma of the skin.J Natl Cancer Inst. 1992 Feb 19;84(4):235-41. doi: 10.1093/jnci/84.4.235. J Natl Cancer Inst. 1992. PMID: 1734084 Clinical Trial.
-
13-cis-retinoic acid plus interferon alpha-2a: highly active systemic therapy for squamous cell carcinoma of the cervix.J Natl Cancer Inst. 1992 Feb 19;84(4):241-5. doi: 10.1093/jnci/84.4.241. J Natl Cancer Inst. 1992. PMID: 1734085 Clinical Trial.
Similar articles
-
Response to 13-cis-retinoic acid plus interferon alfa-2a in two patients with therapy-refractory advanced renal cell carcinoma.J Clin Oncol. 1995 Oct;13(10):2679-80. doi: 10.1200/JCO.1995.13.10.2679. J Clin Oncol. 1995. PMID: 7595723 No abstract available.
-
13-cis-retinoic acid and alpha-interferon in advanced squamous cell cancer of the oesophagus.Eur J Cancer. 1997 Jan;33(1):165-6. doi: 10.1016/s0959-8049(96)00362-0. Eur J Cancer. 1997. PMID: 9071918 Clinical Trial. No abstract available.
-
13-cis-retinoic acid plus interferon-alpha 2a in locally advanced squamous cell carcinoma of the cervix.J Natl Cancer Inst. 1993 Mar 17;85(6):499-500. doi: 10.1093/jnci/85.6.499. J Natl Cancer Inst. 1993. PMID: 8445678 Clinical Trial. No abstract available.
-
Prolonged stabilization of progressive squamous cell cancer of the cervix with interferon-alpha and 13-cis-retinoic acid: report of two cases and review of the literature.Anticancer Drugs. 1996 Sep;7(7):800-4. doi: 10.1097/00001813-199609000-00014. Anticancer Drugs. 1996. PMID: 8949994 Review.
-
Retinoic acid and interferon in human cancer: mechanistic and clinical studies.Semin Hematol. 1994 Oct;31(4 Suppl 5):31-7. Semin Hematol. 1994. PMID: 7831583 Review.
Cited by
-
An Eastern Cooperative Oncology Group phase I trial of all-trans-retinoic acid and interferon-alpha: E2Y92.Invest New Drugs. 1997;15(4):319-24. doi: 10.1023/a:1005985418441. Invest New Drugs. 1997. PMID: 9547674 Clinical Trial.
-
Phase II trial of 13-cis-retinoic acid plus interferon-alpha in recurrent head and neck cancer.Invest New Drugs. 1993 Feb;11(1):57-60. doi: 10.1007/BF00873912. Invest New Drugs. 1993. PMID: 8349437 Clinical Trial.
-
Opposing cytokine-specific effects of all trans-retinoic acid on the activation and expression of signal transducer and activator of transcription (STAT)-1 in THP-1 cells.Immunology. 2002 Oct;107(2):199-208. doi: 10.1046/j.1365-2567.2002.01485.x. Immunology. 2002. PMID: 12383199 Free PMC article.
-
Interferon treatment of human malignancies--a short review.Med Oncol Tumor Pharmacother. 1993;10(1-2):25-9. doi: 10.1007/BF02987765. Med Oncol Tumor Pharmacother. 1993. PMID: 7505041 Review.
-
Combination of highly purified human leukocyte interferon alpha and 13-cis-retinoic acid for the treatment of metastatic melanoma.Cancer Immunol Immunother. 1995 Mar;40(3):157-64. doi: 10.1007/BF01517347. Cancer Immunol Immunother. 1995. PMID: 7728774 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
